Your browser doesn't support javascript.
loading
Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
Giménez Arnau, A M; Valero Santiago, A; Bartra Tomás, J; Jáuregui Presa, I; Labrador Horrillo, M; Miquel Miquel, F J; Ortiz de Frutos, J; Sastre, J; Silvestre Salvador, J F; Ferrer Puga, M.
Afiliação
  • Giménez Arnau AM; Dermatology Department, Hospital del Mar, Institut Mar D´Investigacions Mèdiques, Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Valero Santiago A; Allergy Unit, Pneumology Department, Hospital Clínic, Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL).
  • Bartra Tomás J; Allergy Unit, Pneumology Department, Hospital Clínic, Barcelona, Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL).
  • Jáuregui Presa I; Allergy Department, Hospital Universitario Basurto, Bilbao, Spain.
  • Labrador Horrillo M; Allergology Department, Hospital Universitari Vall d´Hebron, Barcelona, Spain and RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL).
  • Miquel Miquel FJ; Dermatology Department, Hospital Arnau de Vilanova, Valencia, Spain.
  • Ortiz de Frutos J; Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sastre J; Allergology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • Silvestre Salvador JF; Dermatology Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • Ferrer Puga M; Department of Allergy and Immunology, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Pamplona, Spain.
J Investig Allergol Clin Immunol ; 29(5): 338-348, 2019.
Article em En | MEDLINE | ID: mdl-30222111
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antialérgicos / Omalizumab / Urticária Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antialérgicos / Omalizumab / Urticária Crônica Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article